Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Japanese marketing approval granted for AIDS wasting treatment

April 28, 1999

Vertex and Glaxo Wellcome begin shipping new anti-HIV compound

April 27, 1999

Coumarin derivatives with antiviral activity against HIV from Pliva

April 26, 1999

Novel antiviral agent active against HIV-1 and other viruses developed in Russia

April 26, 1999

Metabolism and disposition of novel anti-HIV agent studied in isolated rat liver

April 23, 1999

Eisai research team discovers novel HIV-1 Tat antagonist

April 20, 1999

New, second-generation HIV fusion inhibitor from Trimeris to be evaluated clinically

April 20, 1999

FDA approves amprenavir, first new protease inhibitor in more than two years

April 19, 1999

Pivotal studies of anti-HIV drug candidate under way on three continents

April 16, 1999

AIDSVAX enters clinical trials at U. of Pittsburgh

April 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...